eth 615 has been researched along with n-formylmethionine leucyl-phenylalanine in 1 studies
Studies (eth 615) | Trials (eth 615) | Recent Studies (post-2010) (eth 615) | Studies (n-formylmethionine leucyl-phenylalanine) | Trials (n-formylmethionine leucyl-phenylalanine) | Recent Studies (post-2010) (n-formylmethionine leucyl-phenylalanine) |
---|---|---|---|---|---|
7 | 0 | 0 | 6,716 | 53 | 356 |
Protein | Taxonomy | eth 615 (IC50) | n-formylmethionine leucyl-phenylalanine (IC50) |
---|---|---|---|
fMet-Leu-Phe receptor | Homo sapiens (human) | 0.02 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ahnfelt-Rønne, I; Jinquan, T; Kristensen, M; Larsen, CG; Matsushima, K; Paludan, K; Thestrup-Pedersen, K; Thomsen, MK; Zachariae, C | 1 |
1 other study(ies) available for eth 615 and n-formylmethionine leucyl-phenylalanine
Article | Year |
---|---|
ETH615, a synthetic inhibitor of leukotriene biosynthesis and function, also inhibits the production of and biological responses towards interleukin-8.
Topics: Anti-Inflammatory Agents, Non-Steroidal; Chemotaxis, Leukocyte; Gene Expression Regulation; Humans; Interleukin-8; Leukotriene B4; Monocytes; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Quinolines; Recombinant Proteins; T-Lymphocytes; Transcription, Genetic | 1993 |